- Home
- BTTR vs TOVX Comparison
BTTR vs TOVX Comparison
Compare BTTR & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTTR
- TOVX
- Stock Information
- Founded
- BTTR 1986
- TOVX 2001
- Country
- BTTR United States
- TOVX United States
- Employees
- BTTR N/A
- TOVX N/A
- Industry
- BTTR Beverages (Production/Distribution)
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- BTTR Consumer Staples
- TOVX Health Care
- Exchange
- BTTR Nasdaq
- TOVX Nasdaq
- Market Cap
- BTTR 4.2M
- TOVX 3.5M
- IPO Year
- BTTR N/A
- TOVX 2006
- Fundamental
- Price
- BTTR $2.04
- TOVX $1.21
- Analyst Decision
- BTTR Strong Buy
- TOVX Strong Buy
- Analyst Count
- BTTR 1
- TOVX 1
- Target Price
- BTTR $10.00
- TOVX $6.00
- AVG Volume (30 Days)
- BTTR 52.6K
- TOVX 102.1K
- Earning Date
- BTTR 11-12-2024
- TOVX 11-12-2024
- Dividend Yield
- BTTR N/A
- TOVX N/A
- EPS Growth
- BTTR N/A
- TOVX N/A
- EPS
- BTTR N/A
- TOVX N/A
- Revenue
- BTTR $33,519,000.00
- TOVX N/A
- Revenue This Year
- BTTR $428.61
- TOVX N/A
- Revenue Next Year
- BTTR $25.00
- TOVX N/A
- P/E Ratio
- BTTR N/A
- TOVX N/A
- Revenue Growth
- BTTR N/A
- TOVX N/A
- 52 Week Low
- BTTR $1.58
- TOVX $1.14
- 52 Week High
- BTTR $15.40
- TOVX $17.00
- Technical
- Relative Strength Index (RSI)
- BTTR 47.56
- TOVX 37.37
- Support Level
- BTTR $2.06
- TOVX $1.15
- Resistance Level
- BTTR $2.39
- TOVX $1.34
- Average True Range (ATR)
- BTTR 0.18
- TOVX 0.07
- MACD
- BTTR -0.00
- TOVX 0.01
- Stochastic Oscillator
- BTTR 7.96
- TOVX 7.41
About BTTR Better Choice Company Inc.
Better Choice Co Inc is a pet health and wellness portfolio company, offering consumers a wide variety of recognized premium pet products and hemp-derived CBD supplements. Its portfolio includes kibble and canned dog and cat food, freeze-dried raw dog food and treats, vegan dog food and treats, oral care products, supplements and grooming aids. Its core products sold under the Halo brand are sustainably sourced, derived from real whole meat and no rendered meat meal and include non-GMO fruits and vegetables. Its core products sold under the TruDog brand are made according to nutritional philosophy of fresh, meat-based nutrition and minimal processing.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.